Annual Total Liabilities
$1.28 B
+$175.94 M+15.90%
March 31, 2024
Summary
- As of February 24, 2025, RDY annual total liabilities is $1.28 billion, with the most recent change of +$175.94 million (+15.90%) on March 31, 2024.
- During the last 3 years, RDY annual total liabilities has risen by +$24.23 million (+1.93%).
- RDY annual total liabilities is now -15.77% below its all-time high of $1.52 billion, reached on March 31, 2018.
Performance
RDY Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Liabilities
$1.86 B
-$12.23 M-0.65%
December 31, 2024
Summary
- As of February 24, 2025, RDY quarterly total liabilities is $1.86 billion, with the most recent change of -$12.23 million (-0.65%) on December 31, 2024.
- Over the past year, RDY quarterly total liabilities has increased by +$601.52 million (+47.83%).
- RDY quarterly total liabilities is now -0.65% below its all-time high of $1.87 billion, reached on September 30, 2024.
Performance
RDY Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
RDY Total Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +15.9% | +47.8% |
| 3 y3 years | +1.9% | +37.8% |
| 5 y5 years | +4.5% | +37.8% |
RDY Total Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -4.9% | +15.9% | -0.7% | +78.8% |
| 5 y | 5-year | -4.9% | +25.2% | -0.7% | +92.2% |
| alltime | all time | -15.8% | +1683.5% | -0.7% | +2485.1% |
Dr Reddys Laboratories Limited Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | - | $1.86 B(-0.7%) |
| Sep 2024 | - | $1.87 B(+29.4%) |
| Jun 2024 | - | $1.45 B(+12.7%) |
| Mar 2024 | $1.28 B(+15.9%) | $1.28 B(+2.0%) |
| Dec 2023 | - | $1.26 B(+11.4%) |
| Sep 2023 | - | $1.13 B(+3.2%) |
| Jun 2023 | - | $1.09 B(-1.2%) |
| Mar 2023 | $1.11 B(-18.0%) | $1.11 B(+2.9%) |
| Dec 2022 | - | $1.08 B(+3.4%) |
| Sep 2022 | - | $1.04 B(-14.1%) |
| Jun 2022 | - | $1.21 B(-10.2%) |
| Mar 2022 | $1.35 B(+7.2%) | $1.35 B(+8.6%) |
| Dec 2021 | - | $1.24 B(-2.4%) |
| Sep 2021 | - | $1.27 B(-5.6%) |
| Jun 2021 | - | $1.35 B(+7.1%) |
| Mar 2021 | $1.26 B(+22.9%) | $1.26 B(+11.4%) |
| Dec 2020 | - | $1.13 B(-5.0%) |
| Sep 2020 | - | $1.19 B(+0.6%) |
| Jun 2020 | - | $1.18 B(+15.3%) |
| Mar 2020 | $1.02 B(-16.5%) | $1.02 B(+5.9%) |
| Dec 2019 | - | $967.43 M(-14.8%) |
| Sep 2019 | - | $1.14 B(-2.7%) |
| Jun 2019 | - | $1.17 B(-5.0%) |
| Mar 2019 | $1.23 B(-19.4%) | $1.23 B(-5.6%) |
| Dec 2018 | - | $1.30 B(-8.2%) |
| Sep 2018 | - | $1.42 B(-2.9%) |
| Jun 2018 | - | $1.46 B(-4.2%) |
| Mar 2018 | $1.52 B(+3.1%) | $1.52 B(-4.9%) |
| Dec 2017 | - | $1.60 B(+4.5%) |
| Sep 2017 | - | $1.53 B(+4.6%) |
| Jun 2017 | - | $1.47 B(-0.8%) |
| Mar 2017 | $1.48 B(+23.6%) | $1.48 B(-5.5%) |
| Dec 2016 | - | $1.56 B(-0.7%) |
| Sep 2016 | - | $1.57 B(+30.3%) |
| Jun 2016 | - | $1.21 B(+1.1%) |
| Mar 2016 | $1.19 B(-10.5%) | $1.19 B(+0.3%) |
| Dec 2015 | - | $1.19 B(-3.0%) |
| Sep 2015 | - | $1.23 B(-4.9%) |
| Jun 2015 | - | $1.29 B(-3.2%) |
| Mar 2015 | $1.33 B(+0.6%) | $1.33 B(+6.7%) |
| Dec 2014 | - | $1.25 B(-0.4%) |
| Sep 2014 | - | $1.26 B(-1.8%) |
| Jun 2014 | - | $1.28 B(-3.6%) |
| Mar 2014 | $1.33 B(+3.8%) | $1.33 B(-1.1%) |
| Dec 2013 | - | $1.34 B(+1.7%) |
| Sep 2013 | - | $1.32 B(+4.7%) |
| Jun 2013 | - | $1.26 B(-1.4%) |
| Mar 2013 | $1.28 B | $1.28 B(-0.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2012 | - | $1.28 B(+0.7%) |
| Sep 2012 | - | $1.27 B(+7.8%) |
| Jun 2012 | - | $1.18 B(-2.4%) |
| Mar 2012 | $1.21 B(+10.0%) | $1.21 B(-9.1%) |
| Dec 2011 | - | $1.33 B(+8.8%) |
| Sep 2011 | - | $1.22 B(+11.6%) |
| Jun 2011 | - | $1.09 B(-0.3%) |
| Mar 2011 | $1.10 B(+31.7%) | $1.10 B(+37.3%) |
| Dec 2010 | - | $799.90 M(-6.1%) |
| Sep 2010 | - | $852.07 M(+7.3%) |
| Jun 2010 | - | $794.07 M(-4.8%) |
| Mar 2010 | $833.98 M(+1.3%) | $833.98 M(+20.7%) |
| Dec 2009 | - | $691.09 M(-10.7%) |
| Sep 2009 | - | $773.91 M(+17.7%) |
| Jun 2009 | - | $657.45 M(-20.2%) |
| Mar 2009 | $823.67 M(-13.7%) | $823.67 M(-11.0%) |
| Dec 2008 | - | $924.97 M(-6.3%) |
| Sep 2008 | - | $986.76 M(+1.9%) |
| Jun 2008 | - | $968.29 M(+1.5%) |
| Mar 2008 | $954.42 M(-7.5%) | $954.42 M(+6.4%) |
| Dec 2007 | - | $897.25 M(-0.2%) |
| Sep 2007 | - | $898.69 M(+3.6%) |
| Jun 2007 | - | $867.78 M(-15.9%) |
| Mar 2007 | $1.03 B(-1.4%) | $1.03 B(-6.3%) |
| Dec 2006 | - | $1.10 B(-10.6%) |
| Sep 2006 | - | $1.23 B(+5.5%) |
| Jun 2006 | - | $1.17 B(+11.6%) |
| Mar 2006 | $1.05 B(+447.7%) | $1.05 B(+355.3%) |
| Dec 2005 | - | $229.93 M(+2.7%) |
| Sep 2005 | - | $223.97 M(+1.3%) |
| Jun 2005 | - | $221.03 M(+15.6%) |
| Mar 2005 | $191.13 M(+48.1%) | $191.13 M(+31.1%) |
| Dec 2004 | - | $145.82 M(+1.5%) |
| Sep 2004 | - | $143.60 M(-16.4%) |
| Jun 2004 | - | $171.75 M(+33.1%) |
| Mar 2004 | $129.05 M(+46.9%) | $129.05 M(+21.8%) |
| Dec 2003 | - | $105.99 M(-2.4%) |
| Sep 2003 | - | $108.55 M(+8.6%) |
| Jun 2003 | - | $99.92 M(+13.8%) |
| Mar 2003 | $87.83 M(+22.1%) | $87.83 M(+3.5%) |
| Dec 2002 | - | $84.84 M(+4.6%) |
| Sep 2002 | - | $81.07 M(-5.8%) |
| Jun 2002 | - | $86.08 M(+19.7%) |
| Mar 2002 | $71.92 M(-49.6%) | $71.92 M(-1.5%) |
| Dec 2001 | - | $73.02 M(-1.3%) |
| Sep 2001 | - | $74.01 M(-9.5%) |
| Jun 2001 | - | $81.75 M |
| Mar 2001 | $142.82 M | - |
FAQ
- What is Dr Reddys Laboratories Limited annual total liabilities?
- What is the all time high annual total liabilities for Dr Reddys Laboratories Limited?
- What is Dr Reddys Laboratories Limited annual total liabilities year-on-year change?
- What is Dr Reddys Laboratories Limited quarterly total liabilities?
- What is the all time high quarterly total liabilities for Dr Reddys Laboratories Limited?
- What is Dr Reddys Laboratories Limited quarterly total liabilities year-on-year change?
What is Dr Reddys Laboratories Limited annual total liabilities?
The current annual total liabilities of RDY is $1.28 B
What is the all time high annual total liabilities for Dr Reddys Laboratories Limited?
Dr Reddys Laboratories Limited all-time high annual total liabilities is $1.52 B
What is Dr Reddys Laboratories Limited annual total liabilities year-on-year change?
Over the past year, RDY annual total liabilities has changed by +$175.94 M (+15.90%)
What is Dr Reddys Laboratories Limited quarterly total liabilities?
The current quarterly total liabilities of RDY is $1.86 B
What is the all time high quarterly total liabilities for Dr Reddys Laboratories Limited?
Dr Reddys Laboratories Limited all-time high quarterly total liabilities is $1.87 B
What is Dr Reddys Laboratories Limited quarterly total liabilities year-on-year change?
Over the past year, RDY quarterly total liabilities has changed by +$601.52 M (+47.83%)